Xue Li
Tianjin, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Clinical value of clinicopathological, ultrasonographic features and fibroblast activation protein in evaluating the radioiodine treatment efficacy in papillary thyroid carcinoma.
Journal: Annals of nuclear medicine
Published: October 06, 2025
Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect.
Journal: Frontiers in endocrinology
Published: October 04, 2023
Extrathyroidal extension or tumor size of primary lesion influences thyroid cancer outcomes.
Journal: Nuclear medicine communications
Published: July 13, 2023
Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis.
Journal: Journal of healthcare engineering
Published: December 28, 2021
Effects of high-activity radioactive iodine treatment on renal function in patients with differentiated thyroid carcinoma - retrospective study.
Journal: Endokrynologia Polska
Published: December 13, 2021
Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer.
Journal: Frontiers in endocrinology
Published: July 18, 2021
Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
Journal: Nuclear medicine communications
Published: August 15, 2017
Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer.
Journal: Medicine
Published: September 02, 2016
Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.
Journal: Scientific reports
Published: July 18, 2016
Last Updated: 09/26/2026